Evidence map›Paper›PMID 40550590›Full record

ArticleThe British journal of general practice : the journal of the Royal College of General Practitioners2026

Detecting cancer recurrence in general practice: a Danish national cohort study.

Kasper Grooss, Linda Aagaard Rasmussen, Kaj Sparle Christensen, Anette Fischer Pedersen, Larissa Nekhlyudov, Alina Zalounina Falborg, Peter Vedsted

Abstract read
In one paragraph

Article in The British journal of general practice : the journal of the Royal College of General Practitioners, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kasper GroossResearch Unit for General Practice, Aarhus, Denmark k.grooss@ph.au.dk.ORCID 0000-0003-1099-3539
Linda Aagaard RasmussenResearch Unit for General Practice, Aarhus, Denmark.ORCID 0000-0002-9753-2008
Kaj Sparle ChristensenResearch Unit for General Practice, Aarhus, Denmark.ORCID 0000-0002-0409-2702
Anette Fischer PedersenResearch Unit for General Practice, Aarhus, Denmark.ORCID 0000-0003-0253-3671
Larissa NekhlyudovBrigham and Women's Hospital, Harvard Medical School, Boston, MA, US.ORCID 0000-0001-6747-4209
Alina Zalounina FalborgResearch Unit for General Practice, Aarhus, Denmark.ORCID 0000-0002-1616-9455
Peter VedstedResearch Unit for General Practice, Aarhus, Denmark.ORCID 0000-0003-2113-5599

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGPs may detect cancer recurrences between specialised visits or after completed follow-up. There is limited evidence on diagnostic routes to detecting cancer recurrence.

aimTo examine the level of GP involvement in cancer recurrence detection and to assess the time from the index consultation in general practice to a cancer recurrence diagnosis (diagnostic interval). DESIGN AND

settingThis was a retrospective cohort study linking survey data from 667 Danish general practices with national register data.

methodPatients with a recurrence of seven cancer types diagnosed between 1 January 2022 and 31 May 2024 were included. The patients' GPs provided details on how the recurrence was detected.

resultsThe GP survey achieved a response rate of 1265/2611 (48%). Of 1081 patients with recurrence, 478 (44%) first presented signs or symptoms of recurrence in general practice. Recurrence was diagnosed in 758 patients (70%) while they were under active specialised follow-up, and in 291 patients (27%) after completion of follow-up. Of 352 patients with a symptomatic presentation in general practice, the diagnostic pathway was initiated in general practice in 243 (69%), during subsequent follow-up in 57 (16%), and via other routes in 52 (15%). For patients with general practice-initiated diagnostic pathways, the 50th and 90th percentile of the diagnostic interval was 48 and 251 days for symptomatic presentations and 23 and 125 days for asymptomatic presentations, respectively.

conclusionFour in 10 patients with cancer recurrence had their first point of contact in general practice. However, significant delays were observed. Improving detection pathways for cancer recurrence in general practice may benefit survivors across cancer types.

Indexed as

General PracticeNeoplasm Recurrence, LocalNeoplasmsPractice Patterns, Physicians'AdultAgedDenmarkFemaleHumansMaleMiddle AgedReferral and ConsultationRetrospective Studiescancer survivorscohort studiesgeneral practiceneoplasm recurrencereferral and consultationsurveys and questionnaires

Identifiers

PMID40550590
PMCPMC13060679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.